EVIDENCE FOR A MULTIFOCAL ORIGIN OF PAPILLARY SEROUS CARCINOMA OF THE PERITONEUM

被引:0
|
作者
MUTO, MG
WELCH, WR
MOK, SCH
BANDERA, CA
FISHBAUGH, PM
TSAO, SW
LAU, CC
GOODMAN, HM
KNAPP, RC
BERKOWITZ, RS
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,GYNECOL ONCOL LAB,BOSTON,MA 02115
[2] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DIV GYNECOL ONCOL,BOSTON,MA 02115
[3] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT OBSTET GYNECOL & REPROD BIOL,BOSTON,MA 02115
[4] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DIV WOMENS & PERINATAL PATHOL,BOSTON,MA 02115
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Histopathological evidence suggests that papillary serous carcinoma of the peritoneum (PSCP) may be multifocal in origin. Utilizing a PCR based method to detect tandem repeat polymorphisms in formalin fixed tissue, loss of heterozygosity at eight loci on chromosomes 1, 3, 4, and 17 was studied in sir cases of PSCP. Loss of heterozygosity was assessed at between 5 and 11 tumor sites/patient. Allelic losses at 4 loci (1q32-qter, 3p14.3-21.1, 17q12, 17q21.3-23) were noted. Three cases demonstrated a different pattern of allelic loss at various anatomic sites within the same patient. In an additional case, a mutation of the p53 gene, detected by quantitative PCR followed by single-strand conformation polymorphism analysis, was detected in only 2 of 5 tumor sites. The pattern of allelic loss and;he mutational pattern of the p53 gene varied at tumor sites within the same patient in 4 of 6 cases of PSCP. These findings are consistent with histopathological evidence that PSCP is multifocal in origin.
引用
收藏
页码:490 / 492
页数:3
相关论文
共 50 条
  • [41] PRIMARY PAPILLARY SEROUS NEOPLASIA OF THE PERITONEUM - REPLY
    RAJU, U
    HUMAN PATHOLOGY, 1989, 20 (09) : 924 - 924
  • [42] The development of papillary serous carcinoma of the peritoneum subsequent to endometrial carcinoma: a case report and review of the literature
    Savas, B.
    Percinel, S.
    Ceyhan, K.
    Sertcelik, A.
    Tezcan, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (05) : 1108 - 1114
  • [43] Papillary serous cystadenocarcinoma of the stomach, peritoneum and ovary
    Yen, Chih-Chien
    Tsai, Chien-Sung
    Hsi, Sheng-Chuan
    Yang, Ya-Sung
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2009, 72 (04) : 462 - 462
  • [44] Experience with platinum-paclitaxel chemotherapy in the initial management of papillary serous carcinoma of the peritoneum
    Kennedy, AW
    Markman, M
    Webster, KD
    Kulp, B
    Peterson, G
    Rybicki, LA
    Belinson, JL
    GYNECOLOGIC ONCOLOGY, 1998, 71 (02) : 288 - 290
  • [45] Diagnostic and histogenetic significance of PAX8 expression in papillary serous carcinoma of the peritoneum
    Tong, G.
    Hemale-Bena, D.
    VIRCHOWS ARCHIV, 2009, 455 : 12 - 12
  • [46] Serous surface papillary carcinoma of the peritoneum: Clinical, radiologic, and pathologic findings in 11 patients
    Morita, H
    Aoki, J
    Taketomi, A
    Sato, N
    Endo, K
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (04) : 923 - 928
  • [47] Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: Fact or artifact?
    Goodman, Marc T.
    Shvetsov, Yurii B.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (09) : 2231 - 2235
  • [48] PRIMARY PAPILLARY CARCINOMA OF THE PERITONEUM
    TOCCANIER, MF
    MIGUET, B
    NOUVELLE PRESSE MEDICALE, 1981, 10 (44): : 3653 - 3653
  • [49] Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinoma (vol 84, pg 245, 2002)
    Altaras, MM
    Bernheim, J
    Zehavi, T
    Fishman, A
    GYNECOLOGIC ONCOLOGY, 2002, 84 (03) : 540 - 540
  • [50] SEROUS CARCINOMA OF THE PERITONEUM AFTER OOPHORECTOMY
    WEBER, AM
    HEWETT, WJ
    GAJEWSKI, WH
    CURRY, SL
    OBSTETRICS AND GYNECOLOGY, 1992, 80 (03): : 558 - 560